Analyst firms · Guggenheim · MGNX
Guggenheim MGNX price target and rating history
MacroGenics Inc. (MGNX) · Health Care
Guggenheim rates MacroGenics Inc. (MGNX) Neutral with a $12 price target, as of its latest action on Jul 31, 2024. It has published 5 rating actions on MGNX since November 2021, including 1 upgrade and 3 downgrades.
- Current rating
- Neutral
- Price target
- $12
- Median target, all firms
- Too few
- Actions on MGNX
- 5
Guggenheim price target on MGNX
Every Guggenheim rating on MGNX
- Jul 31, 2024
- Nov 7, 2023
- Mar 17, 2023
- May 4, 2022
- Nov 17, 2021
Questions about Guggenheim and MGNX
- What is Guggenheim's price target for MGNX?
- Guggenheim's latest stated price target for MacroGenics Inc. (MGNX) is $12, from its action on Nov 7, 2023.
- What is Guggenheim's rating on MGNX?
- Guggenheim rates MGNX Neutral, a neutral rating, as of Jul 31, 2024.
- When did Guggenheim last change its view on MGNX?
- On Jul 31, 2024, Guggenheim downgrades to Neutral from Buy.
More MGNX rating histories
All Guggenheim ratingsMGNX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.